PHI with central demyelination of the corpus callosum

How does this condition affect your private health insurance?

Zentrale Demyelinisation des Corpus callosum (CDCC) is a rare neurological disorder characterized by the selective demyelination of the central portion of the corpus callosum, the main white matter tract connecting the cerebral hemispheres. It is often a manifestation of osmotic demyelination syndrome, typically triggered by the rapid correction of chronic hyponatremia. Symptoms vary widely but can include confusion, behavioral changes, dysarthria, dysphagia, quadriparesis, and in severe cases, locked-in syndrome. Diagnosis relies heavily on characteristic MRI findings showing T2 hyperintensity and diffusion restriction. Treatment is primarily supportive, focusing on preventing further electrolyte disturbances and managing symptoms. Prognosis is variable, ranging from complete recovery to significant persistent neurological deficits or even death.